1. Home
  2. NAII vs PMN Comparison

NAII vs PMN Comparison

Compare NAII & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

HOLD

Current Price

$3.20

Market Cap

21.2M

Sector

Health Care

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$9.02

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAII
PMN
Founded
1980
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
23.5M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
NAII
PMN
Price
$3.20
$9.02
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
24.9K
43.4K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$134,440,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.00
N/A
52 Week Low
$2.57
$6.27
52 Week High
$4.40
$39.75

Technical Indicators

Market Signals
Indicator
NAII
PMN
Relative Strength Index (RSI) 49.04 88.77
Support Level $3.06 $7.35
Resistance Level $3.68 $9.26
Average True Range (ATR) 0.18 0.64
MACD -0.05 0.34
Stochastic Oscillator 21.88 97.33

Price Performance

Historical Comparison
NAII
PMN

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: